CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.92 +0.02 (+2.22%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Non-Interest Income (2022 - 2025)

Updated

CytoMed Therapeutics' Non-Interest Income was -$4,931 in Q4 2025.

Analysis

CytoMed Therapeutics (GDTC) Non-Interest Income (2022 - 2025) Analysis & Trends

For FY2025, Non-Interest Income at CytoMed Therapeutics came in at -$4,892.

  • In earlier years, Non-Interest Income was $10,305 in FY2024, -$516,147 in FY2023, -$1.14 million in FY2022 and $5,209 in FY2021.
  • The Q4 2025 figure marks the lowest quarterly Non-Interest Income since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Interest Income (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 CytoMed Therapeutics 10.88 Mn -200,496.58 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,931.15
Jun 30, 2025 30,026.00
Jun 30, 2024 64,277.00
Dec 31, 2023 -23,108.12
Dec 31, 2022 -24,171.97
API Access

CytoMed Therapeutics Non-Interest Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-interest-income&ticker=GDTC&period=max&api_key=YOUR_API_KEY